Impact of rheumatoid arthritis on quality of life, work productivity and resource utilisation: An observational, cross-sectional study in Brazil

Clinical and Experimental Rheumatology

Volumn 31, Issue 3, 2013, Pages 334-340

  da Rocha Castelar Pinheiro, G ^a   Khandker, R K ^b   Sato, R ^b   Rose, A ^c   Piercy, J ^c  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b PFIZER INC   (United States)

^c ADELPHI REAL WORLD   (United Kingdom)

Author keywords

Brazil; Disability; Health resources; Pain; Productivity; Quality of life; Rheumatoid arthritis; Work

Indexed keywords

ACTIVITY IMPAIRMENT QUESTIONNAIRE; ADULT; ARTICLE; BRAZIL; CONSULTATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EUROQOL 5D; FEMALE; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY FATIGUE; HAQ PAIN SCORE; HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSERVATIONAL STUDY; PATIENT INFORMATION; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SELF REPORT;

ARTHRITIS, RHEUMATOID; BRAZIL; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; EFFICIENCY; EMPLOYMENT; FEMALE; HEALTH RESOURCES; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; UNEMPLOYMENT;

EID: 84878366222     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. WORLD HEALTH ORGANISATION: Chronic disease and health promotion, chronic rheumatic conditions. http://www.who.int/chp/topics/rheumatbiric/en/index.html
2. SENNA ER, DE BARROS AL, SILVA EO et al.: Prevalence of rheumatic disease in Brazil: a study using the COPCORD approach. J Rheumatol 2004; 31: 3.
3. COPPER NJ: Economic burden of rheumatoid arthritis: a systematic review. Rheumatology 2000; 39: 28-33.
4. DE AZEVEDO AB, FERRAZ MB, CICONELLI RM: Indirect costs of rheumatoid arthritis in Brazil. Value Health 2008; 11: 869-77.
5. BIRNBAUM H, PIKE C, KAUFMAN R, MAYNCHENKO M, KIDOLEZI Y, CIFALDI M: Societal cost of rheumatoid arthritis patients in the US. Curr Med Res Opin 2010; 26: 77-90.
6. HUSCHER D, MERKESDAL S, THIELE K et al.: Cost of illness in rheumatoid arthritis, ankylosing spondilitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis 2006; 65: 1175-83.
7. LEARDINI G, SALAFFI F, MONTANELLI R et al.: A multicenter cost-of-illness study on rheumatoid arthritis in Italy. Clin Exp Rheumatol 2002; 20: 505-15.
8. RAT AC, BOISSIER MC: Rheumatoid arthritis: direct and indirect costs. Joint Bone Spine 2004; 71: 518-24.
9. SOKKA T, KAUTIAINEN H, PINCUS T et al.: Disparities in rheumatoid arthritis disease activity according to gross domestic productin 25 countries in the QUEST-RA database. Ann Rheum Dis 2009; 68: 1666-72.
10. CHERMONT G, KOWALSKI S, CICONELLI R, FERRAZ M: Resource utilization and the costs of rheumatoid arthritis in Brazil. Clin Exp Rheumatol 2008; 26: 24-31.
11. ANDERSON P, BENFORD M, HARRIS N, KARAVALI M, PIERCY J: Real-world physician and patient behaviour across countries: diseasespecific programmes -a means to understand. Curr Med Res Opin 2008; 24: 3063-72.
12. MAKINEN H, KAUTIAINEN H, HANNONEN P et al.: Disease activity score 28 as an instrument to measure disease activity in patients with early rheumatoid arthritis. J Rheumatol 2007; 34: 1987-91.
13. BRUCE B, FRIES FJ: The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes 2003; 1: 20.
14. SNAITH RP: The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes 2003; 1: 1-29.
15. EUROQOL GROUP: EuroQoL -A new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
16. ESCORPIZO R, BOMBARDIER C, BOONEN A et al.: Worker productivity outcome measures in arthritis. J Rheumatol 2007; 34: 1372-80.
17. CELLA D, YOUNT S, SORENSEN M, CHARTASH E, SENGUPTA N, GROBER J: Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 811-9.
18. HARDIN, JW, HILBE JM: Generalized Estimating Equations. Boca Raton, FL: Chapman & Hall/CRC 2003.
19. D'AGOSTINO, RB, BELANGER AJ, D'AGOSTINO JR. RB: A suggestion for using powerful and informative tests of normality. American Statistician 1990; 44: 316-21.
20. SALAFFI F, CIAPETTI A, GASPARANI S et al.: Comparison of the Recent-Onset Arthritis Disability questionnaire with the Health Assessment Questionnaire disability index in patients with rheumatoid arthritis. Clin Exp Rheumatol 2010; 28: 855-65.
21. CIMMINO MA, LEARDINI G, SALAFFI F et al.: Assessing the cost-effectiveness of biologic agents for the management of moderateto-severe rheumatoid arthritis in anti-TNF inadequate responders in Italy: a modeling approach. Clin Exp Rheumatol 2011; 29: 633-41.
22. LINDE L, SøRENSEN J, øSTERGAARD M, HøRSLEV-PETERSEN, HETLAND ML: Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important? J Rheumatol 2010; 37: 285-90.
23. SALAFFI F, CAROTTI M, CIAPETTI A, GASPARINI S, GRASSI W: A comparison of utility measurements using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis Clin Exp Rheumatol 2011; 29: 661-71.
24. BARTON JL, IMBODEN J, GRAF J, GLIDDEN D, YELIN EH, SCHILLINGER D: Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2010; 62: 857-64.